Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrence”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00005961
What this trial is testing

O6-benzylguanine and Carmustine in Treating Patients With Unresectable Locally Recurrent or Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT00003670
What this trial is testing

Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Metastatic Refractory Ovarian Cancer or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPrimary Peritoneal Cavity Cancer
Eli Lilly and Company
Not applicableEnded earlyNCT02149173
What this trial is testing

F-18 FES PET/CT in Measuring Hormone Expression in Patients With Primary, Recurrent, or Metastatic Breast Cancer Undergoing Endocrine-Targeted Therapy

Who this might be right for
Estrogen Receptor PositiveRecurrent Breast CarcinomaStage IV Breast Cancer AJCC v6 and v7
University of Washington 29
Early research (Phase 1)Not Yet RecruitingNCT07077369
What this trial is testing

WGc-0201 Plus Tislelizumab in HCC With High Risk of Recurrence and Metastasis After Radical Therapy

Who this might be right for
Hepatocellular Carcinoma (HCC)
West China Hospital 10
Testing effectiveness (Phase 2)UnknownNCT06149169
What this trial is testing

CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Large B-cell Lymphoma

Who this might be right for
Lymphoma, Non-HodgkinDiffuse Large B Cell Lymphoma
Shanghai Ming Ju Biotechnology Co., Ltd. 10
Testing effectiveness (Phase 2)Study completedNCT00967369
What this trial is testing

Combination Chemotherapy With or Without Bortezomib in Treating Patients With Classical Hodgkin Lymphoma That Has Returned or Does Not Respond to Prior Treatment.

Who this might be right for
Recurrent Classic Hodgkin LymphomaRefractory Classic Hodgkin Lymphoma
M.D. Anderson Cancer Center 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07005583
What this trial is testing

Clinical Study of QL1706 in Combination With Olaparib for the Treatment of Patients With Previously Treated Homologous Recombination Repair-Deficient Recurrent or Metastatic Triple-Negative Breast Cancer

Who this might be right for
Triple-Negative Breast Cancer (TNBC)
Tianjin Medical University Cancer Institute and Hospital 46
Testing effectiveness (Phase 2)Ended earlyNCT00319683
What this trial is testing

ADH300004 and 5-Fluorouracil in Locally Advanced, Recurrent, or Metastatic Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Adherex Technologies, Inc.
Large-scale testing (Phase 3)Looking for participantsNCT07166094
What this trial is testing

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

Who this might be right for
Endometrial CancerRecurrent or Progressive Endometrial Cancer
Genmab 660
Testing effectiveness (Phase 2)UnknownNCT02060656
What this trial is testing

Phase II Study Comparing LR-GEM to R-GEM-P in Second-line Treatment of Diffuse Large B-cell Lymphoma (LEGEND)

Who this might be right for
Diffuse Large B-Cell Lymphoma
Royal Marsden NHS Foundation Trust 92
Testing effectiveness (Phase 2)Ended earlyNCT00496756
What this trial is testing

Sorafenib in Treating Patients With Metastatic or Unresectable Kidney Cancer

Who this might be right for
Kidney Cancer
University of Nebraska 14
Early research (Phase 1)Study completedNCT00452829
What this trial is testing

Prevention of Neural Tube Defects by Inositol in Conjunction With Folic Acid (PONTI Study)

Who this might be right for
Recurrent Neural Tube Defects
Institute of Child Health 100
Early research (Phase 1)Study completedNCT05344729
What this trial is testing

Clinical Trial for Effect of TQB3616 Capsule on Pharmacokinetics in Healthy Adult Subjects

Who this might be right for
Recurrent/Metastatic Breast Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 16
Testing effectiveness (Phase 2)Ended earlyNCT06912529
What this trial is testing

Axicabtagene Ciloleucel CAR T-cells in Patients With Relapsed or Refractory Primary Mediastinal B-cell Lymphoma

Who this might be right for
B-cell Lymphoma RefractoryB-cell Lymphoma Recurrent
Universität Münster 1
Large-scale testing (Phase 3)UnknownNCT01844453
What this trial is testing

Local Endometrial Injury in Fresh Embryo Transfer Cycles

Who this might be right for
Infertility
McGill University 360
Early research (Phase 1)Study completedNCT05052437
What this trial is testing

PK and Drug Interaction Study of Utidelone Plus Capecitabine in Patients With Advanced Breast Cancer

Who this might be right for
Advanced and Metastatic Breast Cancer
Beijing Biostar Pharmaceuticals Co., Ltd. 16
Not applicableStudy completedNCT06578962
What this trial is testing

Efficacy of a Cosmetic Shampoo RV3438G in Reccurent Squamous States

Who this might be right for
Dermatitis, Seborrheic
Pierre Fabre Dermo Cosmetique 63
Not applicableUnknownNCT06379646
What this trial is testing

An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease

Who this might be right for
Systemic Lupus ErythematosusSystemic SclerosisInflammatory Myopathy+3 more
China Immunotech (Beijing) Biotechnology Co., Ltd. 6
Testing effectiveness (Phase 2)Study completedNCT01876446
What this trial is testing

Pegylated Irinotecan NKTR 102 in Treating Patients With Relapsed Small Cell Lung Cancer

Who this might be right for
Recurrent Small Cell Lung Carcinoma
Roswell Park Cancer Institute 38
Not applicableLooking for participantsNCT06686342
What this trial is testing

PDO Based Drug Sensitive Test in R/M HNSCC

Who this might be right for
Head and Neck Squamous Cell CarcinomaPatient Derived OrganoidDrug Sensitive Test in Vitro
Huashan Hospital 100
Next Page